Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Jacoby

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
The Journal of Hospital Infection|September 1, 1982
Amikacin, gentamicin and tobramycin resistant Pseudomonas aeruginosa in a leukaemic ward. Epidemiology and genetic studiesF R Falkiner, G A Jacoby, C T Keane, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United StatesA Robicsek, J Strahilevitz, D F Sahm, et al.
Journal of Clinical Microbiology|March 1, 1994
Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamasesG P Katsanis, J Spargo, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Evolution of TEM-related extended-spectrum beta-lactamases in KoreaH Pai, H J Lee, E H Choi, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Broader distribution of plasmid-mediated quinolone resistance in the United StatesA Robicsek, D F Sahm, J Strahilevitz, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1982
Effects of azlocillin in combination with clavulanic acid, sulbactam, and N-formimidoyl thienamycin against beta-lactamase-producing, carbenicillin-resistant Pseudomonas aeruginosaS B Calderwood, A Gardella, A M Philippon, et al.
The New England Journal of Medicine|September 15, 1988
Broad-spectrum, transmissible beta-lactamasesG A Jacoby, A A Medeiros, T F O'Brien, et al.
Journal of Clinical Microbiology|September 28, 2001
Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in KoreaH Pai, E H Choi, H J Lee, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830)G M Eliopoulos, K Klimm, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1993
Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum beta-lactamase genesL B Rice, S H Marshall, L L Carias, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
The Journal of Hospital Infection|September 1, 1982
Amikacin, gentamicin and tobramycin resistant Pseudomonas aeruginosa in a leukaemic ward. Epidemiology and genetic studiesF R Falkiner, G A Jacoby, C T Keane, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United StatesA Robicsek, J Strahilevitz, D F Sahm, et al.
Journal of Clinical Microbiology|March 1, 1994
Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamasesG P Katsanis, J Spargo, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Evolution of TEM-related extended-spectrum beta-lactamases in KoreaH Pai, H J Lee, E H Choi, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Broader distribution of plasmid-mediated quinolone resistance in the United StatesA Robicsek, D F Sahm, J Strahilevitz, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1982
Effects of azlocillin in combination with clavulanic acid, sulbactam, and N-formimidoyl thienamycin against beta-lactamase-producing, carbenicillin-resistant Pseudomonas aeruginosaS B Calderwood, A Gardella, A M Philippon, et al.
The New England Journal of Medicine|September 15, 1988
Broad-spectrum, transmissible beta-lactamasesG A Jacoby, A A Medeiros, T F O'Brien, et al.
Journal of Clinical Microbiology|September 28, 2001
Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in KoreaH Pai, E H Choi, H J Lee, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830)G M Eliopoulos, K Klimm, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1993
Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum beta-lactamase genesL B Rice, S H Marshall, L L Carias, et al.
Pageof 8